Ruth Seggewiss‐Bernhardt

1.5k citations
19 papers · 889 indexed · 1 hit paper · h-index 12
Topics
Immune Cell Function and Interaction (8 papers)CAR-T cell therapy research (5 papers)PI3K/AKT/mTOR signaling in cancer (4 papers)

In The Last Decade

Ruth Seggewiss‐Bernhardt

18 papers receiving 876 citations

Hit Papers

Phosphatidylinositol 3-Kinase α–Selective Inhibition With...20182026202020232018100200300

Peers

Ruth Seggewiss‐Bernhardt
Comparison fields: 5 of 69
  • Molecular Biology 434
  • Oncology 409
  • Pulmonary and Respiratory Medicine 232
  • Immunology 214
  • Genetics 152
Replace K. Papadopoulos with:
K. Papadopoulos United States
Stephen Castaneda United States
Ivan Inigo United States
Robert J. Behrens United States
R. Stahel Switzerland
Wendy Walsh Canada
KyungMann Kim United States
Valérie Méresse France
Josep Lluís Parra United Kingdom
Jean Powers Canada
Ruth Seggewiss‐Bernhardt relative to K. Papadopoulos United States K. Papadopoulos's profile →
Citations per field
00.5×1.5×1.8×
K. Papadopoulos · 1×
Citations per year

Countries citing papers authored by Ruth Seggewiss‐Bernhardt

Since Specialization
Citations

This map shows the geographic impact of Ruth Seggewiss‐Bernhardt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruth Seggewiss‐Bernhardt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruth Seggewiss‐Bernhardt more than expected).

Fields of papers citing papers by Ruth Seggewiss‐Bernhardt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ruth Seggewiss‐Bernhardt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruth Seggewiss‐Bernhardt. The network helps show where Ruth Seggewiss‐Bernhardt may publish in the future.

Co-authorship network of co-authors of Ruth Seggewiss‐Bernhardt

This figure shows the co-authorship network connecting the top 25 collaborators of Ruth Seggewiss‐Bernhardt. A scholar is included among the top collaborators of Ruth Seggewiss‐Bernhardt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ruth Seggewiss‐Bernhardt. Ruth Seggewiss‐Bernhardt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
#WorkIndexed citations
1 0
2 22
3 1
4 1
5
Phosphatidylinositol 3-Kinase α–Selective Inhibition With Alpelisib (BYL719) in PIK3CA-Altered Solid Tumors: Results From the First-in-Human Studybreakdown →
302
6 186
7 23
8 138
9 4
10 21
11 3
12 52
13 9
14 19
15 12
16 5
17 37
18 33
19 21

About Ruth Seggewiss‐Bernhardt

Ruth Seggewiss‐Bernhardt is a scholar working on Hematology, Immunology and Oncology, having authored 19 papers that have together received 889 indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (8 papers), CAR-T cell therapy research (5 papers) and PI3K/AKT/mTOR signaling in cancer (4 papers). The work is most often cited by research in Oncology (409 citations), Genetics (152 citations) and Immunology (214 citations). Ruth Seggewiss‐Bernhardt has collaborated with scholars based in Germany, United States and Spain. Frequent co-authors include Douglas Bootle, Martin Schüler, Marta Gil-Martín, Cornelia Quadt, David Demanse, Dejan Juric, José Baselga, Howard A. Burris, Jordi Rodón and Alan Huang. Their work appears in journals such as Journal of Clinical Oncology, PLoS ONE and Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026